Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related HPQ
Worst Performing Industries For November 27, 2015
Fast Money Traders Share The Stocks That Can Be Bought At Discount
Tracking The Hotchkis & Wiley Value Opportunities Fund - Q3 2015 Update (Seeking Alpha)
Related CBMX
New Data From CombiMatrix Study Support Follow-Up Diagnostic Testing to Confirm Positive Results From Non-Invasive Prenatal Testing
CombiMatrix's CombiSNP Array for Prenatal Diagnosis Test Granted Approval by NY State Department of Health

Pre-open movers US stock futures are higher this morning, after Hewlett-Packard Co (NYSE: HPQ) posted better-than-expected fiscal first-quarter results. Futures for the Dow Jones Industrial Average surged 45 points to 13,917.00 and S&P 500 index futures rose 7 points to 1,508.10. Nasdaq 100 futures gained 11 points to 2,725.00.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 1.24%, London's FTSE 100 Index surged 0.83%, French CAC 40 Index rose 1.80% and German DAX 30 index gained 1.22%.

Asian markets ended mixed, with Japan's Nikkei Stock Average gaining 0.68%, China's Shanghai Composite falling 0.51% and Australia's S&P/ASX 200 rising 0.76%. Hong Kong's Hang Seng Index tumbled 0.54% and India's Sensex fell 0.04%.

Broker Recommendation Analysts at UBS upgraded Hewlett-Packard Company (NYSE: HPQ) from “sell” to “neutral.” The target price for Hewlett-Packard is set to $19.

Hewlett-Packard shares surged 4.68% to $17.90 in pre-market trading.

Breaking news

  • CombiMatrix Corporation (NASDAQ: CBMX) today announced that Mark McDonough, currently the Company's Chief Commercial Officer, will become Chief Executive Officer following the retirement of CEO R. Judd Jessup, who has announced his retirement, effective March 15, 2013. To read the full news, click here.
  • Exelixis (NASDAQ: EXEL) and Swedish Orphan Biovitrum (Sobi) today announced that they have entered into a three-year agreement to support the distribution and commercialization of COMETRIQ(TM) (cabozantinib) for metastatic medullary thyroid cancer (MTC) in the European Union (EU) and potentially other countries. To read the full news, click here.
  • Portland General Electric Co (NYSE: POR) reported a 3.4% drop in its fourth-quarter earnings. To read the full news, click here.
  • MSC Industrial Direct Co (NYSE: MSM) today announced that it has signed a definitive agreement to acquire substantially all of the assets and assume certain liabilities of the North American distribution business of the Barnes Group (NYSE: B). To read the full news, click here.

Posted-In: UBS US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (CBMX + B)

View Comments and Join the Discussion!

Get Benzinga's Newsletters